• Issue

    European Journal of Haematology: Volume 104, Issue 5

    i-ii, 359-515
    May 2020
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER IMAGE

Free Access

Front Cover

Koji Jimbo,  Takaaki Konuma,  Motoko Mizukami,  Etsuko Nagai,  Maki Oiwa-Monna,  Masamichi Isobe,  Seiko Kato,  Satoshi Takahashi,  Arinobu Tojo, 
  • Page: i
  • First Published: 17 April 2020
Front Cover

The front cover image is based on the Letter to Editor* Telomere length in CD4+ and CD8+ T cells among long-term survivors of adults after single cord blood transplantation by Takaaki Konuma** et al., https://doi.org/10.1111/ejh.13385.***

Free Access

Back Cover

Reinhard Stauder,  Jérémy Lambert,  Sandra Desruol-Allardin,  Isabelle Savre,  Lona Gaugler,  Igor Stojkov,  Uwe Siebert,  Hélène Chevrou-Séverac, 
  • Page: ii
  • First Published: 17 April 2020
Back Cover

The back cover image is based on the Original Article* Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis by Reinhard Stauder** et al., https://doi.org/10.1111/ejh.13389.***

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 359-360
  • First Published: 17 April 2020

REVIEW ARTICLE

Free Access

Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group

Marietta Nygaard,  Stina Wichert,  Gösta Berlin,  Fredrik Toss, 
  • Pages: 361-375
  • First Published: 07 January 2020

ORIGINAL ARTICLES

Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Göran Wålinder,  Jan Samuelsson,  Per Näsman,  Markus Hansson,  Gunnar Juliusson,  Karin Forsberg,  Ronald Svensson,  Olle Linder,  Kristina Carlson,  Sigurdur Y. Kristinsson,  Ulf Henrik Mellqvist,  Cecilie Hveding Blimark,  Ingemar Turesson,  Hareth Nahi, 
  • Pages: 376-382
  • First Published: 16 November 2019

Tumor load in patients with multiple myeloma: β₂-microglobulin levels versus low-dose whole-body CT

Vanessa Pfahler,  Melvin D'Anastasi,  Hans-Roland Dürr,  Regina Schinner,  Jens Ricke,  Andrea Baur-Melnyk, 
  • Pages: 383-389
  • First Published: 24 November 2019
Open Access

Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015)

Alankrita Taneja,  Vivek Kumar,  Abhinav B. Chandra, 
  • Pages: 390-399
  • First Published: 26 November 2019
Open Access

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era

Antonio Gutierrez,  Leyre Bento,  Antonio Diaz-Lopez,  Gilberto Barranco,  Marta Garcia-Recio,  Armando Lopez-Guillermo,  Ivan Dlouhy,  Jordina Rovira,  Mario Rodriguez,  Jose María Sanchez Pina,  Monica Baile,  Alejandro Martín,  Silvana Novelli,  Juan-Manuel Sancho,  Olga García,  Antonio Salar,  Mariana Bastos-Oreiro,  Mª José Rodriguez-Salazar,  Ruben Fernandez,  Fatima de la Cruz,  Jose Antonio Queizan,  Sonia González de Villambrosia,  Raul Cordoba,  Andres López,  Hugo Luzardo,  Daniel García,  Jordi Sastre-Serra,  Juan Fernando Garcia,  Carlos Montalban,  Fernando Cabanillas,  Jose Rodríguez, 
  • Pages: 400-408
  • First Published: 05 December 2019

Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma

Sarah L. Kvorning,  Marlene C. Nielsen,  Niels F. Andersen,  Marianne Hokland,  Morten N. Andersen,  Holger J. Møller, 
  • Pages: 409-419
  • First Published: 19 December 2019

Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta-analysis

Ghulam Rehman Mohyuddin,  Muhammad Aziz,  Brian McClune,  Al-Ola Abdallah,  Muzaffar Qazilbash, 
  • Pages: 420-426
  • First Published: 27 December 2019
Open Access

Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments

Sam Salek,  Audra N. Boscoe,  Sarah Piantedosi,  Shayna Egan,  Christopher J Evans,  Ted Wells,  Jennifer Cohen,  Robert J. Klaassen,  Rachael Grace,  Michael Storm, 
  • Pages: 427-434
  • First Published: 27 December 2019
Open Access

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Roman Hajek,  Ludek Pour,  Muhit Ozcan,  Jesus Martin Sánchez,  Ramon García Sanz,  Achilles Anagnostopoulos,  Albert Oriol,  Nicola Cascavilla,  Andreas Terjung,  Yihua Lee,  Eva M. Briso,  Edyta Dobkowska,  Bernhard Hauns,  Ivan Špička, 
  • Pages: 435-442
  • First Published: 28 December 2019
Open Access

Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial

Fredrik Schjesvold,  Hartmut Goldschmidt,  Vladimir Maisnar,  Ivan Spicka,  Neils Abildgaard,  Philip Rowlings,  Lauren Cain,  Dorothy Romanus,  Kaveri Suryanarayan,  Vincent Rajkumar,  Dawn Odom,  Ari Gnanasakthy,  Meletios Dimopoulos, 
  • Pages: 443-458
  • First Published: 26 December 2019

Role of pretransplant anti-thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome

Seung-Ah Yahng,  Gi-June Min,  Sung-Soo Park,  Silvia Park,  Young-Woo Jeon,  Jae-Ho Yoon,  Seung-Hwan Shin,  Sung-Eun Lee,  Byung-Sik Cho,  Ki-Seong Eom,  Seok Lee,  Chang-Ki Min,  Hee-Je Kim,  Jong-Wook Lee,  Yoo-Jin Kim, 
  • Pages: 459-468
  • First Published: 20 January 2020
Open Access

Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin’s lymphoma

Xiang Zhou,  Patrick Wuchter,  Gerlinde Egerer,  Mark Kriegsmann,  Felix K. F. Kommoss,  Mathias Witzens-Harig,  Katharina Kriegsmann, 
  • Pages: 469-475
  • First Published: 21 January 2020
Open Access

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

Reinhard Stauder,  Jérémy Lambert,  Sandra Desruol-Allardin,  Isabelle Savre,  Lona Gaugler,  Igor Stojkov,  Uwe Siebert,  Hélène Chevrou-Séverac, 
  • Pages: 476-487
  • First Published: 27 January 2020

Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment

Anne Calleja,  Seongseok Yun,  Chimène Moreilhon,  Jean Michel Karsenti,  Lauris Gastaud,  Lionel Mannone,  Rami Komrokji,  Najla al Ali,  Bérangère Dadone-montaudie,  Guillaume Robert,  Patrick Auberger,  Sophie Raynaud,  David A. Sallman,  Thomas Cluzeau, 
  • Pages: 488-498
  • First Published: 28 January 2020

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

Juan-Manuel Sancho,  Belén Navarro,  Joan Alfons Soler Campos,  Jaime Pérez de Oteyza,  Cristina de Barrenetxea Lekue,  Marco Bregni,  Silvina Grasso Cicala,  Mario Spione,  Cristina Mombiedro,  Begoña Soler,  Pier Luigi Zinzani, 
  • Pages: 499-508
  • First Published: 30 January 2020

LETTERS TO THE EDITOR

Telomere length in CD4+ and CD8+ T cells among long-term survivors of adults after single cord blood transplantation

Koji Jimbo,  Takaaki Konuma,  Motoko Mizukami,  Etsuko Nagai,  Maki Oiwa-Monna,  Masamichi Isobe,  Seiko Kato,  Satoshi Takahashi,  Arinobu Tojo, 
  • Pages: 509-511
  • First Published: 20 January 2020

Ibrutinib as initial therapy in chronic lymphocytic leukemia: A systematic review and meta-analysis

Stefano Molica,  Diana Giannarelli,  Tycho Baumann,  Emili Montserrat, 
  • Pages: 512-515
  • First Published: 20 January 2020